Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases

Cancer

Volumn 97, Issue 3, 2003, Pages 554-560

  Wood, Bradford J ^a,b   Abraham, Jame ^b,c   Hvizda, Julia L ^a   Alexander, H Richard ^b   Fojo, Tito ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Adrenal metastases; Adrenocortical carcinoma; Radiofrequency ablation

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADRENAL METASTASIS; ADRENAL NECROSIS; ADRENAL TUMOR; ARTICLE; CANCER CONTROL; CATHETER ABLATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; EVALUATION; FOLLOW UP; HUMAN; IMAGING; MEDICAL CARE; PATIENT SELECTION; PRIORITY JOURNAL; SAFETY; SURVIVAL TIME; THERMAL INJURY;

ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL CARCINOMA; CATHETER ABLATION; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 0037302792     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11084     Document Type: Article

References (24)

1. Demeure MJ, Somberg LB. Functioning and nonfunctioning adrenocortical carcinoma. Surg Oncol Clin North Am. 1998; 7:791-805.
2. Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy. N Engl J Med.1990;332:1195-1201.
3. Vassilopoulou-Sellin R, Guinee VF, Klein MJ, et al. Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. Cancer. 1993;71:3119-3123.
4. Decker RA, Elson P, Hogan TF, et al. Eastern Cooperative Oncology Group study 1879: mitotane and Adriamycin in patients with advanced adrenocrtical carcinoma. Surgery. 1991;110:1006-1013.
5. Bukowski RM, Wolfe M, Levine HS, et al. Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group Study. J Clin Oncol. 1993;11: 161-165.
6. Rosenthal DI, Hornicek FJ, Wolfe MW, et al. Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg [A]. 1998;80:815-821.
7. Lindner NJ, Scarborough M, Ciccarelli JM, Enneking WF. CT-guided radiofrequency ablation for treatment of osteoid osteoma in comparison to traditional techniques. Z Orthop. 1997;135:522-527.
8. Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound guided radiofrequency electrocautery for the treatment of small hepatocelluar carcinoma. J Interven Radiol. 1993;8:97-103.
9. Solbiati L, Ierace T, Goldberg NS, et al. Percutaneous US-guided radiofrequency tissue ablation of liver metastases: treatment and follow up in 16 patients. Radiology. 1997;202: 195-203.
10. Goldberg SN, Solbiati L, Hahn PF, et al. Large-volume tissue ablation with radio Frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology. 1998;209:371-379.
11. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 1999;230:1-8.
12. Brennan MF. Adrenocortical carcinoma. CA Cancer J Clin. 1987;37:349-365.
13. Kasperlik-Zaluska AA, Migdalska BM, Zgliczynski S, Makowska AM. Adrenocortical carcinoma. Cancer. 1995;75:2587-2591.
14. Wooten MD, King DK. Adrenocortical carcinoma. Cancer. 1993;72:3145-3153.
15. Pommier RF, Brennan MF. An eleven-year experience with adrenocortical carcinoma. Surgery. 1992;112:963-971.
16. Jensen CJ, Pass HI, Sindelar WF, Norton JA. Recurrent or metastatic disease in select patients with adrenocortical carcinoma. Arch Surg. 1991;126:457-461.
17. Bellantone R, Ferrante A, Boscherini M, et al. Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian national registry for adrenal cortical carcinoma. Surgery. 1997;122:1212-1218.
18. Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA. Adrenocortical carcinoma. Cancer. 1989;64:765-769.
19. Abraham J, Bakke S, Rutt A, et al. A phase II study of combination chemotherapy and surgical resection in the treatment of adrenocortical carcinoma: continuous infusion of doxorubicin, vincristine and etoposide with daily mitotane before and after surgical resection [abstract]. Proc Am Soc Clin Oncol. 1999;18:191a.
20. Abraham J, Fojo T, Wood BJ. Radiofrequency ablation of metastatic lesions in adrenocortical cancer. Ann Intern Med. 2000;133:312-313.
21. Pacek K, Fojo T, Goldstein DS, et al. Radiofrequency ablation (RFA): a novel approach for the treatment of metastatic pheochromocytoma. J Natl Cancer Inst. 2001;93:648-649.
22. Paul CA, Virgo KS, Wade TP, Audisio RA, Johnson FE. Adrenalectomy for isolated adrenal metastases from non-adrenal cancer. Int J Oncol. 2000;17:181-187.
23. Lo CY, Van Heerden JA, Soreide JA, et al. Adrenalectomy for metastatic disease to the adrenal glands. Br J Surg. 1996;83: 528-531.
24. Kim SH, Brennan MF, Russo P, Burt ME, Coit DG. The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer. 1998;82:389-394.